|
MED21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13862261233544E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.5185964425134E-11 |
| Normal-vs-Stage2 |
2.01130000432315E-08 |
| Normal-vs-Stage3 |
2.78480000170944E-08 |
| Normal-vs-Stage4 |
5.58339999999768E-05 |
| Stage1-vs-Stage2 |
5.707200E-01 |
| Stage1-vs-Stage3 |
6.484600E-01 |
| Stage1-vs-Stage4 |
9.616400E-01 |
| Stage2-vs-Stage3 |
4.028200E-01 |
| Stage2-vs-Stage4 |
7.668400E-01 |
| Stage3-vs-Stage4 |
7.462000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.65543143029845E-12 |
| Normal-vs-AfricanAmerican |
6.82470000512581E-08 |
| Normal-vs-Asian |
1.356470E-03 |
| Caucasian-vs-AfricanAmerican |
1.856440E-01 |
| Caucasian-vs-Asian |
9.443400E-01 |
| AfricanAmerican-vs-Asian |
6.987800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64834812466097E-12 |
| Normal-vs-Female |
3.25110000032325E-07 |
| Male-vs-Female |
1.091520E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.57640001052783E-09 |
| Normal-vs-Extreme_Weight |
5.23736609636671E-12 |
| Normal-vs-Obese |
1.02779995625468E-09 |
| Normal-vs-Extreme_Obese |
1.67429999975433E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.853600E-01 |
| Normal_Weight-vs-Obese |
3.291200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.492800E-01 |
| Extreme_Weight-vs-Obese |
2.363000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.184200E-01 |
| Obese-vs-Extreme_Obese |
1.007020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.0455999999931E-05 |
| Normal-vs-Age(41-60Yrs) |
3.30170002449393E-10 |
| Normal-vs-Age(61-80Yrs) |
5.28244115116649E-12 |
| Normal-vs-Age(81-100Yrs) |
5.25879999990764E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.759800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.393200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.061010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.802980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.790000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.399400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.53952414652758E-12 |
| Normal-VS-Type2 PRCC |
5.11130027192053E-11 |
| Normal-VS-KIRP CIMP |
2.764900E-04 |
| Normal-VS-Unclassified PRCC |
4.32650000004031E-06 |
| Type1 PRCC-VS-Type2 PRCC |
8.858800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.625600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.811200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.133800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.846600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.618400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.79849526569387E-11 |
| Normal-vs-N1 |
1.68103999999003E-05 |
| Normal-vs-N2 |
2.119300E-03 |
| N0-vs-N1 |
1.038800E-01 |
| N0-vs-N2 |
9.485000E-01 |
| N1-vs-N2 |
3.868600E-01 |
|
|
